Sources of the figures for Bosnia and Herzegovina
| Source | Type | Rows | Indicators | Years | Read from | Retrieved |
|---|---|---|---|---|---|---|
| WHO Global Tuberculosis Programme | Programme record | 87 | 16 | 2000–2024 | extranet.who.int | 2026-10-16 |
| UNAIDS AIDSinfo | Modelled estimate | 74 | 10 | 2000–2024 | aidsinfo.unaids.org | 2026-10-20 |
| WHO Europe Health for All database | Programme record | 40 | 2 | 2000–2019 | dw.euro.who.int | 2026-10-21 |
| IATI, through d-portal | Expenditure account | 39 | 3 | 2002–2026 | d-portal.org | 2026-10-12 |
| OECD Creditor Reporting System | Expenditure account | 30 | 2 | 2002–2023 | sdmx.oecd.org | 2026-10-12 |
| World Bank Open Data | Modelled estimate | 26 | 1 | 2000–2025 | api.worldbank.org | 2026-10-12 |
| HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13 | Programme record | 16 | 2 | 2015–2024 | ecdc.europa.eu | 2026-10-21 |
Indicators held
| Indicator | Domain | Unit | Rows | Years | Sources | Most recent value |
|---|---|---|---|---|---|---|
| Actual expenditure on collaborative TB/HIV activities | Financing | USD | 2 | 2017–2022 | WHO Global Tuberculosis Programme | $3k (2022) |
| Budget required for collaborative TB/HIV activities | Financing | USD | 2 | 2018–2023 | WHO Global Tuberculosis Programme | $6k (2023) |
| Domestic funding received by the national TB programme | Financing | USD | 6 | 2017–2022 | WHO Global Tuberculosis Programme | $47k (2022) |
| Expected Global Fund funding for the national TB programme | Financing | USD | 1 | 2019 | WHO Global Tuberculosis Programme | $2k (2019) |
| Expected USAID funding for the national TB programme | Financing | USD | 1 | 2019 | WHO Global Tuberculosis Programme | $0 (2019) |
| Expected domestic funding for the national TB programme | Financing | USD | 6 | 2018–2023 | WHO Global Tuberculosis Programme | $73k (2023) |
| Expected funding for collaborative TB/HIV activities | Financing | USD | 2 | 2018–2023 | WHO Global Tuberculosis Programme | $6k (2023) |
| External HIV financing (all donors, ODA) | Financing | USD | 20 | 2002–2023 | OECD Creditor Reporting System | $88k (2023) |
| External HIV financing from governments other than the United States (IATI) | Financing | USD | 21 | 2002–2025 | IATI, through d-portal | $0 (2025) |
| External HIV financing from multilateral bodies other than the Global Fund (IATI) | Financing | USD | 7 | 2020–2026 | IATI, through d-portal | $58 (2026) |
| Funding received for collaborative TB/HIV activities | Financing | USD | 2 | 2017–2022 | WHO Global Tuberculosis Programme | $3k (2022) |
| Global Fund HIV disbursements to the country | Financing | USD | 21 | 2006–2016 | IATI, through d-portal, OECD Creditor Reporting System | $504k (2016) |
| Global Fund funding received by the national TB programme | Financing | USD | 2 | 2018–2022 | WHO Global Tuberculosis Programme | $0 (2022) |
| USAID funding received by the national TB programme | Financing | USD | 2 | 2018–2022 | WHO Global Tuberculosis Programme | $0 (2022) |
| % of PLHIV on ART (second 95, PLHIV base) | Treatment cascade | percent | 2 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| % of estimated HIV-positive incident TB cases on TB treatment and ART | Treatment cascade | percent | 6 | 2008–2016 | UNAIDS AIDSinfo | 46.7% (2016) |
| % of people newly enrolled in HIV treatment diagnosed with TB disease | Treatment cascade | percent | 3 | 2014–2016 | UNAIDS AIDSinfo | 100.0% (2016) |
| % of people newly enrolled in HIV treatment started on TB preventive therapy | Treatment cascade | percent | 3 | 2014–2016 | UNAIDS AIDSinfo | 100.0% (2016) |
| HIV-exposed infants tested within two months of birth | Treatment cascade | percent | 2 | 2012–2013 | UNAIDS AIDSinfo | 98.0% (2013) |
| HIV-positive TB patients started or continued on ART | Treatment cascade | count | 1 | 2016 | WHO Global Tuberculosis Programme | 1 (2016) |
| New HIV diagnoses with a CD4 count below 200 | Treatment cascade | percent | 2 | 2015–2016 | UNAIDS AIDSinfo | 37.0% (2016) |
| Notified HIV cases, national case surveillance | Treatment cascade | count | 30 | 2000–2024 | HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13, WHO Europe Health for All database | 40 (2024) |
| People newly enrolled on ART during the year | Treatment cascade | count | 3 | 2014–2016 | WHO Global Tuberculosis Programme | 2 (2016) |
| TB patients recorded as HIV-positive | Treatment cascade | count | 1 | 2016 | WHO Global Tuberculosis Programme | 1 (2016) |
| TB patients with an HIV test result recorded | Treatment cascade | count | 6 | 2015–2022 | WHO Global Tuberculosis Programme | 29 (2022) |
| Deaths from TB among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 0 (2024) |
| HIV prevalence among a key population | Epidemic estimates | percent | 3 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Incident TB cases among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 1 (2024) |
| People newly reported with AIDS, national surveillance | Epidemic estimates | count | 26 | 2000–2024 | HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13, WHO Europe Health for All database | 19 (2024) |
| Estimated size of a key population | Population denominators | count | 3 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Total population | Population denominators | count | 26 | 2000–2025 | World Bank Open Data | 3,140,095 (2025) |
Every row shown on the Bosnia and Herzegovina page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.
Turn your phone to read the chart upright